Inadequate Investigator Knowledge Reported in Clinical Trial Audits
Inadequate Investigator Knowledge Reported in Clinical Trial Audits Why Inadequate Investigator Knowledge Leads to Audit Findings Introduction: Investigator Knowledge as a Pillar of GCP Compliance Clinical investigators play a central role in safeguarding participant safety and ensuring trial credibility. Regulators including the FDA, EMA, and MHRA emphasize that investigators must demonstrate adequate knowledge of the…
Read More “Inadequate Investigator Knowledge Reported in Clinical Trial Audits” »